SK biopharmaceuticals
에스케이바이오팜KRX: 326030· Fiscal year 2025· skbp.com ↗
Average salary
$90.5K
₩120.5M
▲ 21.8% vs 2024
Employees
272
▲ 2.6% vs 2024
Average tenure
6.3 yrs
Estimated take-home of this pay:$5.7K / monthCalculate →
Workplace
Women's pay (men = 100)84
Women among staff50%
Contract staff8.5%
Recent official filings
- 2026-11-16Quarterly report (2026.09)
- 2026-11-13Investor relations (IR) event
- 2026-11-05Preliminary earnings (consolidated)
- 2026-11-02Investor relations (IR) event
- 2026-09-23Supply contract signed
- 2026-09-14Supply contract signed
Quick read
- Average pay is 97% above the median of the companies we track.
- Average pay rose 21.8% from 2024.
- Headcount grew by 7 (2.6%) from 2024.
- Ranks #16 of 166 Services & Education companies in this country by pay.
- Revenue grew 29.1% year over year.
- Revenue has grown two years in a row.
- Operating margin was 28.9% in 2025.
- Operating loss of $28.1M in 2023.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $1.9M
- Net profit per employee
- $697.2K
- Operating margin
- 28.9%
- Net margin
- 35.8%
- ROE
- 30.7%
- Debt-to-equity
- 45.0%
- Equity ratio
- 69.0%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.